Which are the causes of Wiskott-Aldrich syndrome?

Wiskott-Aldrich syndrome is a rare, X-linked primary immunodeficiency caused by mutations in the WAS gene, which provides instructions for making the WAS protein (WASP). This genetic defect disrupts the proper function of blood cells, leading to the classic triad of immune deficiency, eczema, and low platelet counts (thrombocytopenia). Because it is an X-linked condition, it primarily affects males, with the underlying genetic cause being well-understood by researchers.

What causes Wiskott-Aldrich syndrome?

The primary cause of Wiskott-Aldrich syndrome is a mutation in the WAS gene located on the X chromosome. This gene is responsible for producing the WAS protein, which acts like a "cellular architect." In healthy individuals, this protein helps organize the internal structure (cytoskeleton) of white blood cells and platelets. When the WAS gene is mutated, the resulting WAS protein is either absent or non-functional. Without this architect, blood cells cannot properly change shape, move to sites of infection, or interact with other cells, which is why Wiskott-Aldrich syndrome leads to such complex immune dysfunction.

Is Wiskott-Aldrich syndrome hereditary?

Yes, Wiskott-Aldrich syndrome is an inherited genetic condition. It follows an X-linked recessive pattern of inheritance. Because males have only one X chromosome, a single mutated copy of the WAS gene is sufficient to cause the disease. Females have two X chromosomes; if one carries the mutation, the other usually provides a functional copy, meaning females are typically "carriers" who do not show symptoms but can pass the gene to their children. In about 25% to 33% of cases, the condition arises from a spontaneous (de novo) mutation in the patient, meaning it was not inherited from either parent.

What are the biological mechanisms behind the symptoms?

The absence of the WAS protein triggers a cascade of issues that define Wiskott-Aldrich syndrome. Because the cytoskeleton of platelets is malformed, they are small and are prematurely destroyed by the spleen, leading to the characteristic low platelet count. Furthermore, the immune system is unable to mount effective responses to bacteria, viruses, and fungi because white blood cells cannot effectively signal or migrate. The clinical manifestations of Wiskott-Aldrich syndrome include:

• Thrombocytopenia: Abnormally small platelets and low platelet counts, often resulting in easy bruising or bleeding.


• Immunodeficiency: Increased susceptibility to recurrent infections, particularly ear infections, pneumonia, and meningitis.


• Eczema: Severe, persistent skin inflammation that is often a hallmark of the condition.


• Autoimmune risks: An increased likelihood of developing autoimmune disorders, such as vasculitis or hemolytic anemia, because the immune system is "confused" by the lack of proper regulation.

Are there environmental triggers for the disease?

Wiskott-Aldrich syndrome is entirely genetic, meaning it is not caused by environmental factors, lifestyle, or exposures during pregnancy. However, environmental factors can exacerbate the symptoms of Wiskott-Aldrich syndrome. For example, exposure to common pathogens can trigger severe infections due to the weakened immune system, and environmental allergens can make the associated eczema much more difficult to manage. It is important to distinguish that while these factors do not cause the disease, they significantly influence the daily health experience of individuals living with it.

How is research currently advancing our understanding?

Current research into Wiskott-Aldrich syndrome is focused on gene therapy, which aims to correct the genetic defect at its source by introducing a functional copy of the WAS gene into the patient's own stem cells. Scientists are also investigating the specific signaling pathways that go awry when the WAS protein is missing. At DiseaseMaps.org, we have seen 7 individuals share their journeys with Wiskott-Aldrich syndrome, highlighting the importance of ongoing clinical trials and genetic research in improving long-term outcomes for families affected by this condition.

Next steps

• Consult with a clinical immunologist or a hematologist who has specific experience with primary immunodeficiencies.


• Request a referral to a genetic counselor to discuss family planning and carrier testing for relatives.


• Connect with the DiseaseMaps.org community to share experiences and learn from other families navigating Wiskott-Aldrich syndrome.


• Monitor for clinical trials focused on gene therapy or hematopoietic stem cell transplantation (HSCT) via the NIH ClinicalTrials.gov database.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the guidance of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Wiskott-Aldrich syndrome.


• Orphanet: Wiskott-Aldrich syndrome (ORPHA:908).


• Online Mendelian Inheritance in Man (OMIM): WAS gene (#301000).


• Immune Deficiency Foundation (IDF): Resources on Wiskott-Aldrich syndrome.